Capricor Therapeutics
CAPR
#7981
Rank
โ‚ฌ0.24 B
Marketcap
5,46ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-61.80%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ96.39 M55.74%
2024โ‚ฌ61.89 M1584.06%
2023โ‚ฌ3.67 M24.67%
2022โ‚ฌ2.94 M-49.93%
2021โ‚ฌ5.88 M-88.57%
2020โ‚ฌ51.49 M573.14%
2019โ‚ฌ7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Cytokinetics
CYTK
โ‚ฌ18.27 Mโ‚ฌ35.97 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ1.61 Mโ‚ฌ4.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ54.31 Mโ‚ฌ94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ2.71 Mโ‚ฌ30.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ7.65 Mโ‚ฌ11.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/Aโ‚ฌ2.11 M๐Ÿ‡บ๐Ÿ‡ธ USA